IgA肾病-话题@MedSci

#IgA肾病#

34篇内容 | 1237人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2190875, encodeId=97ad21908e529, content=<a href='/topic/show?id=0a0b5496306' target=_blank style='color:#2F92EE;'>#抑郁#</a> <a href='/topic/show?id=146246308d1' target=_blank style='color:#2F92EE;'>#宫颈癌#</a> <a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a> <a href='/topic/show?id=e0f192e4701' target=_blank style='color:#2F92EE;'>#超加工食品#</a>, objectTitle=‘四大顶刊’一周研究导读：对于低风险宫颈癌，单纯与根治性子宫切除术孰优？；抗抑郁竟如此简单？跳舞、散步、慢跑、瑜伽……；超加工食品可增加32种疾病风险；学校尿液筛查对早期发现IgA肾病的成本效益, objectType=article, longId=815843, objectId=5c07815843ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221201/1669967667900_4754896.jpeg, objectUrl=/article/show_article.do?id=5c07815843ad, replyNumber=0, likeNumber=26, createdTime=2024-03-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5c07815843ad, moduleTitle=‘四大顶刊’一周研究导读：对于低风险宫颈癌，单纯与根治性子宫切除术孰优？；抗抑郁竟如此简单？跳舞、散步、慢跑、瑜伽……；超加工食品可增加32种疾病风险；学校尿液筛查对早期发现IgA肾病的成本效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c07815843ad)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2189705, encodeId=d9cb2189e05f8, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a> <a href='/topic/show?id=dc2b4e4537e' target=_blank style='color:#2F92EE;'>#尿液检测#</a>, objectTitle=JAMA子刊：学校尿液筛查对早期发现IgA肾病的成本效益, objectType=article, longId=815023, objectId=623c815023f7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240227/1709018384962_5490734.png, objectUrl=/article/show_article.do?id=623c815023f7, replyNumber=0, likeNumber=22, createdTime=2024-02-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=623c815023f7, moduleTitle=JAMA子刊：学校尿液筛查对早期发现IgA肾病的成本效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=623c815023f7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2184104, encodeId=bb6121841045f, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a> <a href='/topic/show?id=02f82693d9' target=_blank style='color:#2F92EE;'>#APRIL#</a> <a href='/topic/show?id=c2ba110566e8' target=_blank style='color:#2F92EE;'>#Sibeprenlimab#</a>, objectTitle=NEJM：Sibeprenlimab治疗IgA肾病患者的2期试验结果出炉！, objectType=article, longId=810855, objectId=97848108554e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240123/34ca11babfe244c1841ec89316e07822.jpg, objectUrl=/article/show_article.do?id=97848108554e, replyNumber=0, likeNumber=29, createdTime=2024-01-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=97848108554e, moduleTitle=NEJM：Sibeprenlimab治疗IgA肾病患者的2期试验结果出炉！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97848108554e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2182851, encodeId=a78a218285111, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a> <a href='/topic/show?id=831d1103065e' target=_blank style='color:#2F92EE;'>#双重内皮素血管紧张素受体拮抗剂#</a>, objectTitle=Lancet：比较Sparsentan和厄贝沙坦在治疗IgA肾病中的有效性和安全, objectType=article, longId=810131, objectId=24f68101317e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301012/1697104022695_2570354.jpg, objectUrl=/article/show_article.do?id=24f68101317e, replyNumber=0, likeNumber=25, createdTime=2024-01-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=24f68101317e, moduleTitle=Lancet：比较Sparsentan和厄贝沙坦在治疗IgA肾病中的有效性和安全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24f68101317e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2172012, encodeId=a9f521e2012fb, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a> <a href='/topic/show?id=f9bb3691817' target=_blank style='color:#2F92EE;'>#厄贝沙坦#</a> <a href='/topic/show?id=2254108036db' target=_blank style='color:#2F92EE;'>#Sparsentan#</a>, objectTitle=Lancet： Sparsentan与厄贝沙坦在IgA肾病患者中的疗效和安全性的比较（PROTECT研究）, objectType=article, longId=802973, objectId=0ab68029e331, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021540666_4754896.webp, objectUrl=/article/show_article.do?id=0ab68029e331, replyNumber=0, likeNumber=42, createdTime=2023-11-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0ab68029e331, moduleTitle=Lancet： Sparsentan与厄贝沙坦在IgA肾病患者中的疗效和安全性的比较（PROTECT研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ab68029e331)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1414623, encodeId=260914146231a, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=J Autoimmun：磷酸酶控制细胞因子介导的半乳糖缺陷型IgA1（IgA肾病的主要自身抗原）过量产生, objectType=article, longId=737608, objectId=3d6ce37608a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d6ce37608a5, replyNumber=0, likeNumber=53, createdTime=2022-09-03, rootId=0, userName=huiwelcome, userId=cd7c3073380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d6ce37608a5, moduleTitle=J Autoimmun：磷酸酶控制细胞因子介导的半乳糖缺陷型IgA1（IgA肾病的主要自身抗原）过量产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d6ce37608a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1414622, encodeId=62d61414622cf, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=HCQ对IgA肾病患者的蛋白尿可能有轻微的收益, objectType=article, longId=733275, objectId=b8f2e3327561, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8f2e3327561, replyNumber=0, likeNumber=52, createdTime=2022-07-27, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8f2e3327561, moduleTitle=HCQ对IgA肾病患者的蛋白尿可能有轻微的收益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8f2e3327561)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1414621, encodeId=7ece1414621b3, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=欧盟批准Calliditas的Kinpeygo治疗原发性IgA肾病, objectType=article, longId=732811, objectId=b62be32811e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b62be32811e3, replyNumber=0, likeNumber=52, createdTime=2022-07-21, rootId=0, userName=huiwelcome, userId=cd7c3073380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b62be32811e3, moduleTitle=欧盟批准Calliditas的Kinpeygo治疗原发性IgA肾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b62be32811e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1414620, encodeId=98bd141462013, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=JAMA：历经10年，终于确证激素对于IgA肾病的治疗效果（TESTING研究）, objectType=article, longId=727287, objectId=c5fee272872f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5fee272872f, replyNumber=0, likeNumber=46, createdTime=2022-05-20, rootId=0, userName=huiwelcome, userId=cd7c3073380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5fee272872f, moduleTitle=JAMA：历经10年，终于确证激素对于IgA肾病的治疗效果（TESTING研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5fee272872f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1414619, encodeId=630214146194a, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=Kidney Int Rep：南亚前瞻性纵向观察IgA肾病队列的三年临床结果, objectType=article, longId=301120, objectId=63b6301120e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63b6301120e5, replyNumber=0, likeNumber=45, createdTime=2022-03-20, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63b6301120e5, moduleTitle=Kidney Int Rep：南亚前瞻性纵向观察IgA肾病队列的三年临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63b6301120e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1414618, encodeId=855d1414618b4, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=Front Med：C4d是狼疮性肾炎和IgA肾病临床结果的筛选工具和独立预测因子。, objectType=article, longId=301118, objectId=21c1301118dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21c1301118dd, replyNumber=0, likeNumber=52, createdTime=2022-03-20, rootId=0, userName=huiwelcome, userId=cd7c3073380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21c1301118dd, moduleTitle=Front Med：C4d是狼疮性肾炎和IgA肾病临床结果的筛选工具和独立预测因子。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21c1301118dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1414617, encodeId=8ec9141461e29, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=Front Immunol:313例捷克IgA肾病患者肾移植后的转归, objectType=article, longId=294958, objectId=1ab4294958bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ab4294958bf, replyNumber=0, likeNumber=44, createdTime=2022-02-01, rootId=0, userName=huiwelcome, userId=cd7c3073380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ab4294958bf, moduleTitle=Front Immunol:313例捷克IgA肾病患者肾移植后的转归, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ab4294958bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1414616, encodeId=b392141461698, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=Front Immunol：IgA肾病风险预测模型比较的验证研究, objectType=article, longId=294957, objectId=f20729495e98, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f20729495e98, replyNumber=0, likeNumber=60, createdTime=2022-02-01, rootId=0, userName=huiwelcome, userId=cd7c3073380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f20729495e98, moduleTitle=Front Immunol：IgA肾病风险预测模型比较的验证研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f20729495e98)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1414615, encodeId=e9e514146156e, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=Front Immunol：高中性粒细胞与淋巴细胞比值是终末期IgA肾病的独立危险因素, objectType=article, longId=294589, objectId=fc272945897b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc272945897b, replyNumber=0, likeNumber=43, createdTime=2022-01-25, rootId=0, userName=huiwelcome, userId=cd7c3073380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc272945897b, moduleTitle=Front Immunol：高中性粒细胞与淋巴细胞比值是终末期IgA肾病的独立危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc272945897b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1414614, encodeId=020b1414614db, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=EBioMedicine：红细胞增多与IgA肾病有关, objectType=article, longId=294147, objectId=022329414ebe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=022329414ebe, replyNumber=0, likeNumber=40, createdTime=2022-01-19, rootId=0, userName=huiwelcome, userId=cd7c3073380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=022329414ebe, moduleTitle=EBioMedicine：红细胞增多与IgA肾病有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=022329414ebe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1414613, encodeId=566f141461325, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=Front Immunol：尿可溶性CD163水平可以预测IgA肾病缓解状态, objectType=article, longId=294146, objectId=88c529414628, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88c529414628, replyNumber=0, likeNumber=44, createdTime=2022-01-19, rootId=0, userName=huiwelcome, userId=cd7c3073380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88c529414628, moduleTitle=Front Immunol：尿可溶性CD163水平可以预测IgA肾病缓解状态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88c529414628)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1414612, encodeId=28201414612fa, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=Sci Rep：静脉冲击注射甲基强的松龙联合小剂量强的松治疗高危IgA肾病, objectType=article, longId=294092, objectId=604929409250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=604929409250, replyNumber=0, likeNumber=49, createdTime=2022-01-18, rootId=0, userName=huiwelcome, userId=cd7c3073380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=604929409250, moduleTitle=Sci Rep：静脉冲击注射甲基强的松龙联合小剂量强的松治疗高危IgA肾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=604929409250)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1414611, encodeId=ca0b1414611a9, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=KIDNEY INT REP：牛津分类法在IgA肾病类固醇治疗中的应用, objectType=article, longId=219057, objectId=849021905e56, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=849021905e56, replyNumber=0, likeNumber=48, createdTime=2021-10-24, rootId=0, userName=huiwelcome, userId=cd7c3073380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=849021905e56, moduleTitle=KIDNEY INT REP：牛津分类法在IgA肾病类固醇治疗中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=849021905e56)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1414610, encodeId=c0ba141461047, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=Clin J Am Soc Nephrol：成人肾移植术后IgA肾病的复发情况如何？, objectType=article, longId=216122, objectId=c8e321612251, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8e321612251, replyNumber=0, likeNumber=46, createdTime=2021-08-23, rootId=0, userName=huiwelcome, userId=cd7c3073380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8e321612251, moduleTitle=Clin J Am Soc Nephrol：成人肾移植术后IgA肾病的复发情况如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8e321612251)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1414609, encodeId=26c6141460982, content=<a href='/topic/show?id=c83e94827d' target=_blank style='color:#2F92EE;'>#IgA肾病#</a>, objectTitle=Sparsentan治疗IgA肾病（IgAN），EMA已授予Sparsentan“孤儿药称号”, objectType=article, longId=207390, objectId=460c20e390d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=460c20e390d3, replyNumber=0, likeNumber=55, createdTime=2021-02-22, rootId=0, userName=huiwelcome, userId=cd7c3073380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=460c20e390d3, moduleTitle=Sparsentan治疗IgA肾病（IgAN），EMA已授予Sparsentan“孤儿药称号”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=460c20e390d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IgA肾病

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#抑郁# #宫颈癌# #IgA肾病# #超加工食品#

‘四大顶刊’一周研究导读：对于低风险宫颈癌，单纯与根治性子宫切除术孰优？；抗抑郁竟如此简单？跳舞、散步、慢跑、瑜伽……；超加工食品可增加32种疾病风险；学校尿液筛查对早期发现IgA肾病的成本效益

2024-03-04发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#IgA肾病# #尿液检测#

JAMA子刊：学校尿液筛查对早期发现IgA肾病的成本效益

2024-02-27发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#IgA肾病# #APRIL# #Sibeprenlimab#

NEJM：Sibeprenlimab治疗IgA肾病患者的2期试验结果出炉！

2024-01-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#IgA肾病# #双重内皮素血管紧张素受体拮抗剂#

Lancet：比较Sparsentan和厄贝沙坦在治疗IgA肾病中的有效性和安全

2024-01-20发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#IgA肾病# #厄贝沙坦# #Sparsentan#

Lancet： Sparsentan与厄贝沙坦在IgA肾病患者中的疗效和安全性的比较（PROTECT研究）

2023-11-30发表于上海

huiwelcome (审核中...)

前往app查看评论内容

#IgA肾病#

J Autoimmun：磷酸酶控制细胞因子介导的半乳糖缺陷型IgA1（IgA肾病的主要自身抗原）过量产生

2022-09-03

爆笑小医 (审核中...)

前往app查看评论内容

#IgA肾病#

HCQ对IgA肾病患者的蛋白尿可能有轻微的收益

2022-07-27

huiwelcome (审核中...)

前往app查看评论内容

#IgA肾病#

欧盟批准Calliditas的Kinpeygo治疗原发性IgA肾病

2022-07-21

huiwelcome (审核中...)

前往app查看评论内容

#IgA肾病#

JAMA：历经10年，终于确证激素对于IgA肾病的治疗效果（TESTING研究）

2022-05-20

docwu2019 (审核中...)

前往app查看评论内容

#IgA肾病#

Kidney Int Rep：南亚前瞻性纵向观察IgA肾病队列的三年临床结果

2022-03-20

huiwelcome (审核中...)

前往app查看评论内容

#IgA肾病#

Front Med：C4d是狼疮性肾炎和IgA肾病临床结果的筛选工具和独立预测因子。

2022-03-20

huiwelcome (审核中...)

前往app查看评论内容

#IgA肾病#

Front Immunol:313例捷克IgA肾病患者肾移植后的转归

2022-02-01

huiwelcome (审核中...)

前往app查看评论内容

#IgA肾病#

Front Immunol：IgA肾病风险预测模型比较的验证研究

2022-02-01

huiwelcome (审核中...)

前往app查看评论内容

#IgA肾病#

Front Immunol：高中性粒细胞与淋巴细胞比值是终末期IgA肾病的独立危险因素

2022-01-25

huiwelcome (审核中...)

前往app查看评论内容

#IgA肾病#

EBioMedicine：红细胞增多与IgA肾病有关

2022-01-19

huiwelcome (审核中...)

前往app查看评论内容

#IgA肾病#

Front Immunol：尿可溶性CD163水平可以预测IgA肾病缓解状态

2022-01-19

huiwelcome (审核中...)

前往app查看评论内容

#IgA肾病#

Sci Rep：静脉冲击注射甲基强的松龙联合小剂量强的松治疗高危IgA肾病

2022-01-18

huiwelcome (审核中...)

前往app查看评论内容

#IgA肾病#

KIDNEY INT REP：牛津分类法在IgA肾病类固醇治疗中的应用

2021-10-24

huiwelcome (审核中...)

前往app查看评论内容

#IgA肾病#

Clin J Am Soc Nephrol：成人肾移植术后IgA肾病的复发情况如何？

2021-08-23

huiwelcome (审核中...)

前往app查看评论内容

#IgA肾病#

Sparsentan治疗IgA肾病（IgAN），EMA已授予Sparsentan“孤儿药称号”

2021-02-22

科室
- - 订阅+
  - 更多科室
工具
服务